Luxembourg Institute of Health
The Luxembourg Institute of Health (LIH) is a public research institute (établissement public) of the Grand Duchy of Luxembourg, registered with the Registre de Commerce et des Sociétés (RCS Luxembourg) under number J34 and listed there as active. LIH operates under the Law of 3 December 2014 on the organisation of Luxembourg’s public research centres, which entered into force on 1 January 2015 and merged the former Centre de Recherche Public-Santé (CRP-Santé) with the Integrated BioBank of Luxembourg (IBBL) to form the institute in its current legal shape. CRP-Santé itself traces back to the Grand-Ducal Regulation of 18 April 1988, adopted under the framework Law of 9 March 1987 on the organisation of research and technological development in the public sector. The on-file incorporation date of 1 January 1988 reflects this 1988 origin only approximately: the creating instrument is dated 18 April, not 1 January, and the institute’s present name and legal structure date only from 2015.
LIH conducts biomedical and precision-medicine research, with programmes in oncology, infection and immunity, and population health, and it runs the Integrated BioBank of Luxembourg as one of its research infrastructures. Recent public sources list a Dudelange facility alongside the institute’s registered office at 1A-1B, Rue Thomas Edison, L-1445 Strassen, Luxembourg; the Dudelange location corresponds to IBBL’s historic biobanking site. LIH sits under the supervision of Luxembourg’s Ministry of Higher Education and Research and is funded principally through State appropriations rather than commercial share capital. As an établissement public, it has no shareholders in the ordinary corporate sense; Luxembourg’s Trésorerie de l’État lists LIH among the State’s public-law participations.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
Shareholders of Luxembourg Institute of Health
Not applicable. Luxembourg Institute of Health (LIH) is a public research institute (établissement public) created and governed under the Law of 3 December 2014 on the organisation of Luxembourg’s public research centres. It has no share capital, shareholders, or ultimate beneficial owners in the sense used for private commercial companies, and the on-file record confirms no shareholder filing exists for this entity. Luxembourg’s Trésorerie de l’État (the State treasury) lists LIH among its public-law “participations,” which reflects the institute’s status as a body of Luxembourg public law rather than an equity stake held by private investors. No RCS Luxembourg filing, government source, or LIH governance disclosure identifies any commercial shareholder, private investor, or beneficial owner of the institute.
Governance and funding
LIH is administered by a government-appointed Board of Directors (conseil d’administration). The Board serving from 1 January 2025 to 31 December 2029 is chaired by Ana Sanchez-Guevara Sanchez (President) with Xavier Poos as Vice-President, alongside external members from the healthcare, scientific, financial and public-administration sectors, plus a staff-delegation representative and a Consultative Council representative; a Government Commissioner (Pierre Misteri, of the Ministry of Higher Education and Research) also sits on the Board to represent State oversight. LIH is funded principally through State appropriations under multi-year performance agreements with the Ministry of Higher Education and Research, supplemented by competitive national and EU research grants, rather than by shareholder capital.
Data availability
Not applicable: as a State-established public research institute without share capital, LIH has no shareholder or beneficial-ownership register to disclose. This section instead reports the institute’s verified governance and funding structure based on official Luxembourg government sources, current as of the retrieval date below.
Sources
- Légilux, Loi du 3 décembre 2014 ayant pour objet l’organisation des centres de recherche publics, legilux.public.lu/eli/etat/leg/loi/2014/12/03/n2/jo – retrieved 18 September 2026
- Trésorerie de l’État (Luxembourg), Luxembourg Institute of Health (LIH) participation record, tresorerie.public.lu/fr/participations/personne_morale_droit_public/19886400112.html – retrieved 18 September 2026
- Luxembourg Institute of Health, Governance & Administration, lih.lu/en/governance/ – retrieved 18 September 2026
Officers
Directors and officers of Luxembourg Institute of Health
Luxembourg Institute of Health (LIH) is led by an executive management team headed by Chief Executive Officer Prof. Dr. Ulf Nehrbass, supported by Deputy Chief Executive Officer Dr. Frank Glod and Chief Financial and Administrative Officer Stefan Debast, per the institute’s own governance disclosures. Strategic oversight sits with a government-appointed Board of Directors rather than the executive team alone. The Board term running from 1 January 2025 to 31 December 2029 is chaired by Ana Sanchez-Guevara Sanchez (President, Associate Medical Director, Robert Schuman Hospitals) with Xavier Poos (Deputy Administrative Director, Health Directorate, Ministry of Health) as Vice-President. Other confirmed external Board members for this term include Lysiane Back, Rudi Balling, Françoise Berthet, Alexandre Bisdorff, Magali Boers, Alain Kohl and Céline Marchand, together with Jérémie Langlet representing the Consultative Council and Miguel Campos representing the staff delegation. Pierre Misteri sits on the Board as Government Commissioner for the Ministry of Higher Education and Research. Nationality and residence are not disclosed for Board or executive members in the sources reviewed for this profile.
Recent officer changes
The Luxembourg government confirmed the current external Board membership with effect from 1 January 2025 for a five-year term, announced on 10 December 2024. Several members, including Xavier Poos, Lysiane Back and Françoise Berthet, were reappointed, while others, including President Ana Sanchez-Guevara Sanchez, Rudi Balling, Alexandre Bisdorff and Céline Marchand, were newly appointed. No change to the Chief Executive Officer position was identified in the sources reviewed.
Data availability
Partial: LIH’s own website discloses current executive and Board membership, but as a public établissement it is not searchable through the ordinary commercial-register officer filings used for private companies, and appointment dates, nationality and residence are not published for individual Board or executive members. The information above reflects the institute’s own governance disclosures and official government appointment announcements as verified on the retrieval date.
Sources
- Luxembourg Institute of Health, Governance & Administration, lih.lu/en/governance/ – retrieved 18 September 2026
- Luxembourg Institute of Health, “New Leadership for the Luxembourg Institute of Health” (10 December 2024), lih.lu/en/article/new-leadership-for-the-luxembourg-institute-of-health/ – retrieved 18 September 2026
- Trésorerie de l’État (Luxembourg), Luxembourg Institute of Health (LIH) participation record, tresorerie.public.lu/fr/participations/personne_morale_droit_public/19886400112.html – retrieved 18 September 2026
Group Structure
Group structure of Luxembourg Institute of Health
Luxembourg Institute of Health (LIH) is an independent public research institute; it has no verified parent company or sister company in the ordinary corporate sense. LIH was itself formed on 1 January 2015, when the Law of 3 December 2014 merged the former Centre de Recherche Public-Santé (CRP-Santé) with the Integrated BioBank of Luxembourg (IBBL); IBBL continues to operate as an integrated research infrastructure within LIH rather than as a separate legal entity. The same 2014 law simultaneously created two other Luxembourg public research centres, the Luxembourg Institute of Science and Technology (LIST, from the merger of CRP Henri Tudor and CRP Gabriel Lippmann) and the Luxembourg Institute of Socio-Economic Research (LISER, renamed from CEPS/INSTEAD). LIST and LISER share the same legal framework and government supervision as LIH but are separate legal entities with their own RCS Luxembourg registrations; this is a shared regulatory framework, not a verified corporate group relationship. LIH also maintains a long-standing research collaboration with the University of Luxembourg, documented on the University’s own website, though this is a research partnership rather than a corporate ownership link. Possible relationships (unverified as corporate links) exist with Luxembourg hospitals such as the Robert Schuman Hospitals, reflecting clinical-research collaboration and overlapping Board membership rather than any confirmed ownership or control relationship.
Verified corporate relationships
No verified parent company, subsidiary, or sister company under common ownership was identified for Luxembourg Institute of Health in the sources reviewed; as a public établissement without share capital, no ownership-percentage table applies.
Recent structural changes
The institute’s principal verified structural change is its own creation: the 2015 merger of CRP-Santé and IBBL into LIH under the Law of 3 December 2014, effective 1 January 2015. No acquisition, disposal, or further merger involving LIH was identified after that date.
Data availability
Partial: LIH’s institutional lineage and its relationship to sibling public research centres are documented in Luxembourg legislation and official sources, but no corporate shareholding or ownership register applies to a public établissement of this kind, so no parent/subsidiary ownership percentages can be reported.
Sources
- Légilux, Loi du 3 décembre 2014 ayant pour objet l’organisation des centres de recherche publics, legilux.public.lu/eli/etat/leg/loi/2014/12/03/n2/jo – retrieved 18 September 2026
- University of Luxembourg, “Luxembourg Institute of Health – LIH”, uni.lu/life-en/descom/lih/ – retrieved 18 September 2026
- Paperjam, “The holy trinity of Luxembourg’s public research ecosystem”, en.paperjam.lu/article/the-holy-trinity-of-the-public-research-ecosystem – retrieved 18 September 2026
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
What is the Luxembourg Institute of Health?
The Luxembourg Institute of Health (LIH) is a public research institute (établissement public) of the Grand Duchy of Luxembourg, registered under RCS Luxembourg number J34, that conducts biomedical and precision-medicine research in oncology, infection and immunity, and population health.
What is Luxembourg Institute of Health's registration number?
LIH is registered with the Registre de Commerce et des Sociétés (RCS Luxembourg) under number J34. The "J" prefix is used by RCS Luxembourg for entities such as public institutions (établissements publics), rather than the "B" prefix used for ordinary commercial companies, which is consistent with LIH being a State-created public body rather than a private company.
Is Luxembourg Institute of Health a private company?
No. LIH is a public research institute (établissement public) created by Luxembourg law. It has no share capital, private shareholders, or ultimate beneficial owners; it is funded principally by the Luxembourg State.
When was Luxembourg Institute of Health founded, and how precise is the 1 January 1988 incorporation date on file?
The on-file incorporation date of 1 January 1988 is a year-only placeholder rather than an exact founding date. Official sources trace LIH's institutional origin to the Grand-Ducal Regulation of 18 April 1988, which created its predecessor, the Centre de Recherche Public-Santé (CRP-Santé), under the framework Law of 9 March 1987 on the organisation of research and technological development in the public sector. The institute's current name and legal structure, however, date only from 1 January 2015.
What was Luxembourg Institute of Health previously called?
LIH was previously known as the Centre de Recherche Public-Santé (CRP-Santé), established in 1988. It adopted the Luxembourg Institute of Health name on 1 January 2015, when the Law of 3 December 2014 merged CRP-Santé with the Integrated BioBank of Luxembourg (IBBL).
What law governs Luxembourg Institute of Health today?
LIH operates under the Law of 3 December 2014 on the organisation of Luxembourg's public research centres, which entered into force on 1 January 2015.
Does Luxembourg Institute of Health have shareholders?
No. As a public établissement, LIH has no shareholders or share capital. It is funded principally through State appropriations under performance agreements with the Ministry of Higher Education and Research, supplemented by competitive research grants.
Who is the Chief Executive Officer of Luxembourg Institute of Health?
Prof. Dr. Ulf Nehrbass is the Chief Executive Officer of LIH, supported by Deputy CEO Dr. Frank Glod and Chief Financial and Administrative Officer Stefan Debast, per the institute's own governance disclosures.
Who chairs Luxembourg Institute of Health's Board of Directors?
Ana Sanchez-Guevara Sanchez chairs the Board of Directors as President for the term running from 1 January 2025 to 31 December 2029, with Xavier Poos as Vice-President.
What does Luxembourg Institute of Health research?
LIH conducts biomedical research focused on precision medicine, with programmes in oncology, infection and immunity, and population health, and it operates the Integrated BioBank of Luxembourg (IBBL) as a research infrastructure.
Where is Luxembourg Institute of Health located?
LIH's registered office is at 1A-1B, Rue Thomas Edison, L-1445 Strassen, Luxembourg. Recent public sources also list a Dudelange facility, corresponding to IBBL's historic biobanking site; the on-file record shows Dudelange as the recorded city.
Is Luxembourg Institute of Health part of a corporate group?
No verified parent, subsidiary, or sister-company relationship exists for LIH in the ordinary corporate sense. It shares its governing legal framework with two other Luxembourg public research centres, LIST and LISER, created under the same 2014 law, but each is a separate legal entity.
What is the Integrated BioBank of Luxembourg's relationship to Luxembourg Institute of Health?
The Integrated BioBank of Luxembourg (IBBL) was merged into LIH on 1 January 2015 under the Law of 3 December 2014 and continues to operate as an integrated research infrastructure within LIH rather than as a separate legal entity.
Does Luxembourg Institute of Health's active registry status mean it is financially stable?
No. An active status on the RCS Luxembourg register confirms that LIH is currently registered; it is not evidence of financial performance, and no compliance or risk conclusion should be drawn from registry status alone.